Riskpilot← Back to searchSign inGet full accessDIAFRAGMA AS
ASActiveOrg 925893560Rotvollen 22, 5235 RådalPhysiotherapy activities · NACE 8695Est. 20201 employees
Revenue 2024
NOK 1,6M
+3% vs 2023
EBITDA margin
16.9%
+4% vs 2023
Equity ratio
34.5%
Financial strength
Net profit 2024
NOK 209K
+4% vs 2023
| Revenue | NOK 1,6M | +3% |
| EBITDA | NOK 268K | +4% |
| Net profit | NOK 209K | +4% |
| Total assets | NOK 401K | +14% |
| Equity | NOK 138K | +7% |
| Employees | 1 | — |
Legal name
DIAFRAGMA AS
Org number
925893560
Legal form
Aksjeselskap
NACE code
8695 · Physiotherapy activities
Founded
3. november 2020
Share capital
NOK 30 000
Employees
1 (FTE)
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Company purpose
Fysikalsk behandling og andre produkter/tjenester som naturlig hører sammen med dette, herunder å delta i andre selskap med lignende virksomhet, og kjøp og salg av aksjer eller på annen måte gjøre seg interessert i andre foretak.
Address
Rotvollen 22, 5235 Rådal
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 350 | 1 419 | 1 398 | 1 546 | 1 588 |
| Staff expenses | −256 | −1 002 | −954 | −1 039 | −1 084 |
| EBITDA | 39 | 160 | 185 | 257 | 268 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 |
| EBIT | 39 | 160 | 185 | 257 | 268 |
| Net financials | 0 | −0 | −0 | −1 | −0 |
| Profit before tax | 39 | 160 | 185 | 256 | 267 |
| Tax | 9 | 24 | 51 | 56 | 59 |
| Net profit | 31 | 136 | 134 | 200 | 209 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 248 | 376 | 434 | 351 | 401 |
| Equity | 61 | 46 | 80 | 130 | 138 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 187 | 330 | 354 | 222 | 263 |
| Total debt | 187 | 330 | 354 | 222 | 263 |
EBITDA margin
16.9%
This company
15.8%
Market median
+7% vs market
20202024
Equity ratio
34.5%
This company
38.2%
Market median
+10% vs market
20202024
Return on equity
151.0%
This company
18.4%
Market median
+721% vs market
20202024
Net profit margin
13.1%
This company
8.1%
Market median
+62% vs market
20202024
Asset turnover
3.96×
This company
1.12×
Market median
+254% vs market
20202024
Debt / equity
1.90×
This company
0.62×
Market median
-206% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-10-21 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
EH Chief Executive Officer | Chief Executive Officer | 2020 |
No data on file.
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of DIAFRAGMA AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Eirik Håskjold Leivestad | Chief Executive Officer | 0 companies |